Vistagen Therapeutics, Inc.
VTGN • NASDAQ
Vistagen Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shawn K. Singh, with a market cap of $22.0M.
Market Cap$22.0M
Employees37.0
CEOShawn K. Singh
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsJun 16, 2026 · in 2 monthsQ4 2026
Financials
Vistagen Therapeutics, Inc. FAQ
Common questions about Vistagen Therapeutics, Inc.
Vistagen Therapeutics, Inc. is scheduled to report earnings for Q4 2026 on June 16, 2026. Analysts estimate revenue of $332.4K.
Vistagen Therapeutics, Inc. has approximately 37 employees.